glutamic acid has been researched along with bay 11-7082 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Blank, T; Dolga, AM; Eisel, UL; Granic, I; Knaus, HG; Luiten, PG; Nijholt, IM; Spiess, J | 1 |
| Datusalia, AK; Sharma, SS | 1 |
| Emad Aboulhoda, B; Gamal, M; Magdy, S; Mohammed, HS; Rashed, L; Samir, NF; Sharawy, N | 1 |
3 other study(ies) available for glutamic acid and bay 11-7082
| Article | Year |
|---|---|
TNF-alpha-mediates neuroprotection against glutamate-induced excitotoxicity via NF-kappaB-dependent up-regulation of K2.2 channels.
Topics: Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Embryo, Mammalian; Enzyme Inhibitors; Glutamic Acid; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; NF-kappa B; Nitriles; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; RNA, Small Interfering; Small-Conductance Calcium-Activated Potassium Channels; Subcellular Fractions; Sulfones; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation | 2008 |
NF-κB Inhibition Resolves Cognitive Deficits in Experimental Type 2 Diabetes Mellitus through CREB and Glutamate/GABA Neurotransmitters Pathway.
Topics: Animals; Avoidance Learning; Blood Glucose; Brain; Cognition Disorders; CREB-Binding Protein; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Enzyme Inhibitors; gamma-Aminobutyric Acid; Glutamic Acid; Insulin; Male; Maze Learning; NF-kappa B; Nitriles; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Signal Transduction; Sulfones | 2016 |
IκB kinase inhibition remodeled connexins, pannexin-1, and excitatory amino-acid transporters expressions to promote neuroprotection of galantamine and morphine.
Topics: Animals; Anti-Inflammatory Agents; Brain; Connexins; Disease Models, Animal; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Galantamine; Glutamic Acid; I-kappa B Kinase; Lipopolysaccharides; Male; Morphine; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroglia; Neurons; Neuroprotection; Neuroprotective Agents; Nitriles; Rats, Sprague-Dawley; Signal Transduction; Sulfones | 2021 |